Definitive Healthcare expands Atlas Technology Install Dataset
15 8월 2023 - 5:05AM
Definitive Healthcare (Nasdaq: DH), an industry leader in
healthcare commercial intelligence, today announced it has
significantly expanded the technology installation data within its
Atlas Dataset.
In the coming months, the Atlas Technology Install Dataset will
receive updates to more than 1.7 million technology installations
for hospitals, health systems, ambulatory surgery centers, and
physician groups. With this new data, overall coverage of
technology installs by vendors will increase by nearly 10% and
technology installs by products by more than 20%. Clients will
benefit from accurate intelligence on hospital, physician, and
ambulatory surgery center usage of technology across 15 primary
categories such as clinical systems, electronic health records
(EHR), health information management (HIM), human resources, and
more.
In addition to better data on confirmed technology
installations, Definitive Healthcare has also added a “Signaling
Strength Score” into its technology data, which provides
intelligence on installations that are not confirmed but that
Definitive Healthcare’s proprietary data-science algorithms have
inferred as installations.
With confirmed and inferred technology installation data
integrated with reference and affiliation data, clients can more
confidently understand how healthcare providers are interconnected
and how technology is deployed across multiple facilities,
locations, and organizations. Using this new technology
installation data from the Atlas Dataset will better enable
Definitive Healthcare clients to identify new opportunities more
quickly and displace competitive solutions.
“In today’s macroeconomic environment, if you are selling
technology to provider organizations, you have to target the
facilities most likely to purchase your product,” said Robert
Musslewhite, CEO of Definitive Healthcare. “The updated technology
data in our Atlas Dataset paints a current, accurate picture of a
provider organization’s technology environment, so that you can
customize your outreach and messaging based on a facility’s current
technology profile, and ultimately close more deals.”
The Atlas Technology Install Dataset is part of Definitive
Healthcare’s industry-leading Atlas Dataset, which was recently
ranked as the top choice among diversified clients for reference
and affiliation data. In June 2023, the company expanded the Atlas
Dataset by increasing all-payor claims data by 5%, launching the
new Atlas Behavioral Health Dataset, and surpassing 1.5 million
healthcare executive contacts.
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data,
analytics, and expertise into healthcare commercial intelligence.
We help clients uncover the right markets, opportunities, and
people, so they can shape tomorrow’s healthcare industry. Our SaaS
platform creates new paths to commercial success in the healthcare
market, so companies can identify where to go next. Learn more
at definitivehc.com.
Forward-Looking Statements
This press release contains certain
forward-looking statements that are subject to the safe harbors
created under the Securities Act of 1933, as amended, and the
Securities Exchange Act of 1934, as amended. All statements other
than statements of historical fact are statements that could be
deemed forward-looking statements. This press release contains
forward-looking statements that are subject to the safe harbors
created under the Securities Act of 1933, as amended, and the
Securities Exchange Act of 1934, as amended. All statements other
than statements of historical fact are statements that could be
deemed forward-looking statements. Words such as “anticipates,”
“expects,” “intends,” “goals,” “plans,” “believes,” “seeks,”
“estimates,” “continues,” “may,” “will,” “would,” “should,”
“could,” “strives,” “projects,” “designed,” and variations of such
words and similar expressions are intended to identify such
forward-looking statements. In addition, statements regarding the
timing, certainty, or impact of new or expanded product features,
data sets, and functionality, or their value to customers are
forward-looking statements. For additional discussion of factors
that could impact our operational and financial results, refer to
our Annual Report on Form 10-K for the fiscal year ended December
31, 2022, our Quarterly Reports on Form 10-Q, Current Reports on
Form 8-K, and our other subsequent SEC filings, which are or will
be available on the Investor Relations page of our website at
ir.definitivehc.com and on the SEC website at www.sec.gov. All
information in this press release speaks only as of the date on
which it is made. We undertake no obligation to publicly update
this information, whether as a result of new information, future
developments or otherwise, except as may be required by law.
Media Contacts: Danielle
Johns djohns@definitivehc.com
Highwire
PR: definitivehealthcare@highwirepr.com
Investor Relations Contact: Brian
Denyeau ICR for Definitive
Healthcare brian.denyeau@icrinc.com
Definitive Healthcare (NASDAQ:DH)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Definitive Healthcare (NASDAQ:DH)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024